AUPH logo

Aurinia Pharmaceuticals (AUPH) CAPEX

annual CAPEX:

$281.00K-$437.00K(-60.86%)
December 31, 2024

Summary

  • As of today (May 31, 2025), AUPH annual capital expenditures is $281.00 thousand, with the most recent change of -$437.00 thousand (-60.86%) on December 31, 2024.
  • During the last 3 years, AUPH annual CAPEX has fallen by -$1.22 million (-81.28%).
  • AUPH annual CAPEX is now -96.17% below its all-time high of $7.34 million, reached on December 31, 2020.

Performance

AUPH CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

quarterly CAPEX:

$17.00K-$39.00K(-69.64%)
March 31, 2025

Summary

  • As of today (May 31, 2025), AUPH quarterly capital expenditures is $17.00 thousand, with the most recent change of -$39.00 thousand (-69.64%) on March 31, 2025.
  • Over the past year, AUPH quarterly CAPEX has increased by +$5000.00 (+41.67%).
  • AUPH quarterly CAPEX is now -99.60% below its all-time high of $4.28 million, reached on September 30, 2020.

Performance

AUPH quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CAPEX:

$286.00K+$5000.00(+1.78%)
March 31, 2025

Summary

  • As of today (May 31, 2025), AUPH TTM capital expenditures is $286.00 thousand, with the most recent change of +$5000.00 (+1.78%) on March 31, 2025.
  • Over the past year, AUPH TTM CAPEX has increased by +$65.00 thousand (+29.41%).
  • AUPH TTM CAPEX is now -96.56% below its all-time high of $8.31 million, reached on March 31, 2021.

Performance

AUPH TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

AUPH CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-60.9%+41.7%+29.4%
3 y3 years-81.3%-78.5%-28.3%
5 y5 years+178.2%-92.0%-2.7%

AUPH CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.3%at low-96.7%+122.1%-68.6%+266.7%
5 y5-year-96.2%+178.2%-99.6%+112.0%-96.6%+266.7%
alltimeall time-96.2%+1024.0%-99.6%+112.0%-96.6%>+9999.0%

AUPH CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$17.00K(-69.6%)
$286.00K(+1.8%)
Dec 2024
$281.00K(-60.9%)
$56.00K(-56.6%)
$281.00K(-1.1%)
Sep 2024
-
$129.00K(+53.6%)
$284.00K(+264.1%)
Jun 2024
-
$84.00K(+600.0%)
$78.00K(-64.7%)
Mar 2024
-
$12.00K(-79.7%)
$221.00K(-69.2%)
Dec 2023
$718.00K(+145.9%)
$59.00K(-176.6%)
$718.00K(-9.5%)
Sep 2023
-
-$77.00K(-133.9%)
$793.00K(-12.9%)
Jun 2023
-
$227.00K(-55.4%)
$910.00K(+26.0%)
Mar 2023
-
$509.00K(+279.9%)
$722.00K(+147.3%)
Dec 2022
$292.00K(-80.5%)
$134.00K(+235.0%)
$292.00K(-36.7%)
Sep 2022
-
$40.00K(+2.6%)
$461.00K(-20.5%)
Jun 2022
-
$39.00K(-50.6%)
$580.00K(+45.4%)
Mar 2022
-
$79.00K(-73.9%)
$399.00K(-73.4%)
Dec 2021
$1.50M(-79.6%)
$303.00K(+90.6%)
$1.50M(-55.6%)
Sep 2021
-
$159.00K(-212.0%)
$3.38M(-54.9%)
Jun 2021
-
-$142.00K(-112.0%)
$7.50M(-9.7%)
Mar 2021
-
$1.18M(-45.9%)
$8.31M(+13.2%)
Dec 2020
$7.34M(+7170.3%)
$2.18M(-49.0%)
$7.34M(+41.5%)
Sep 2020
-
$4.28M(+540.6%)
$5.19M(+452.0%)
Jun 2020
-
$668.00K(+213.6%)
$940.00K(+219.7%)
Mar 2020
-
$213.00K(+634.5%)
$294.00K(+191.1%)
Dec 2019
$101.00K(+36.5%)
$29.00K(-3.3%)
$101.00K(+8.6%)
Sep 2019
-
$30.00K(+36.4%)
$93.00K(+47.6%)
Jun 2019
-
$22.00K(+10.0%)
$63.00K(-12.5%)
Mar 2019
-
$20.00K(-4.8%)
$72.00K(-2.7%)
Dec 2018
$74.00K(+196.0%)
$21.00K(>+9900.0%)
$74.00K(+19.4%)
Sep 2018
-
$0.00(-100.0%)
$62.00K(0.0%)
Jun 2018
-
$31.00K(+40.9%)
$62.00K(+44.2%)
Mar 2018
-
$22.00K(+144.4%)
$43.00K(+72.0%)
Dec 2017
$25.00K(0.0%)
$9000.00(>+9900.0%)
$25.00K(-24.2%)
Sep 2017
-
$0.00(-100.0%)
$33.00K(-10.8%)
Jun 2017
-
$12.00K(+200.0%)
$37.00K(+32.1%)
Mar 2017
-
$4000.00(-76.5%)
$28.00K(+12.0%)
Dec 2016
$25.00K(-50.0%)
$17.00K(+325.0%)
$25.00K(+212.5%)
Sep 2016
-
$4000.00(+33.3%)
$8000.00(-63.6%)
Jun 2016
-
$3000.00(+200.0%)
$22.00K(-46.3%)
Mar 2016
-
$1000.00(>+9900.0%)
$41.00K(-18.0%)
Dec 2015
$50.00K(-44.4%)
$0.00(-100.0%)
$50.00K(-29.6%)
Sep 2015
-
$18.00K(-18.2%)
$71.00K(-4.1%)
Jun 2015
-
$22.00K(+120.0%)
$74.00K(-25.3%)
Mar 2015
-
$10.00K(-52.4%)
$99.00K(+10.0%)
Dec 2014
$90.00K(-16.7%)
$21.00K(0.0%)
$90.00K(+2.3%)
Sep 2014
-
$21.00K(-55.3%)
$88.00K(-14.6%)
Jun 2014
-
$47.00K(+4600.0%)
$103.00K(0.0%)
Mar 2014
-
$1000.00(-94.7%)
$103.00K(-4.6%)
Dec 2013
$108.00K(+175.5%)
$19.00K(-47.2%)
$108.00K(+9.4%)
Sep 2013
-
$36.00K(-23.4%)
$98.70K(+32.5%)
Jun 2013
-
$47.00K(+683.3%)
$74.50K(+105.8%)
Mar 2013
-
$6000.00(-38.1%)
$36.20K(-7.7%)
Dec 2012
$39.20K
$9700.00(-17.8%)
$39.20K(-65.8%)
Sep 2012
-
$11.80K(+35.6%)
$114.50K(+132.3%)
Jun 2012
-
$8700.00(-3.3%)
$49.30K(-28.8%)
DateAnnualQuarterlyTTM
Mar 2012
-
$9000.00(-89.4%)
$69.20K(-94.0%)
Dec 2011
$1.15M(+1253.9%)
$85.00K(-259.2%)
$1.15M(+5.9%)
Sep 2011
-
-$53.40K(-286.7%)
$1.09M(-7.0%)
Jun 2011
-
$28.60K(-97.4%)
$1.17M(+0.9%)
Mar 2011
-
$1.09M(+5093.3%)
$1.16M(+1262.2%)
Dec 2010
$85.00K(-63.4%)
$21.00K(-24.7%)
$85.00K(-35.3%)
Sep 2010
-
$27.90K(+51.6%)
$131.40K(-36.8%)
Jun 2010
-
$18.40K(+4.0%)
$207.90K(-4.3%)
Mar 2010
-
$17.70K(-73.7%)
$217.30K(-6.4%)
Dec 2009
$232.10K(-31.1%)
$67.40K(-35.4%)
$232.10K(-11.6%)
Sep 2009
-
$104.40K(+275.5%)
$262.60K(+21.3%)
Jun 2009
-
$27.80K(-14.5%)
$216.40K(-25.8%)
Mar 2009
-
$32.50K(-66.8%)
$291.70K(-13.4%)
Dec 2008
$336.90K(-61.2%)
$97.90K(+68.2%)
$336.90K(-36.5%)
Sep 2008
-
$58.20K(-43.5%)
$530.30K(-28.0%)
Jun 2008
-
$103.10K(+32.7%)
$736.40K(-1.9%)
Mar 2008
-
$77.70K(-73.3%)
$751.00K(-13.4%)
Dec 2007
$867.40K(-29.0%)
$291.30K(+10.2%)
$867.50K(-5.5%)
Sep 2007
-
$264.30K(+124.6%)
$918.40K(-26.2%)
Jun 2007
-
$117.70K(-39.4%)
$1.24M(+4.8%)
Mar 2007
-
$194.20K(-43.2%)
$1.19M(-2.8%)
Dec 2006
$1.22M(+67.3%)
$342.20K(-42.0%)
$1.22M(-7.2%)
Sep 2006
-
$590.50K(+871.2%)
$1.32M(+43.8%)
Jun 2006
-
$60.80K(-73.4%)
$915.50K(+1.4%)
Mar 2006
-
$228.20K(-47.8%)
$903.00K(+23.7%)
Dec 2005
$730.20K(-16.1%)
$436.90K(+130.4%)
$730.20K(+76.3%)
Sep 2005
-
$189.60K(+292.5%)
$414.10K(-43.3%)
Jun 2005
-
$48.30K(-12.8%)
$730.80K(-5.6%)
Mar 2005
-
$55.40K(-54.1%)
$774.50K(-11.0%)
Dec 2004
$870.10K(-61.5%)
$120.80K(-76.1%)
$870.10K(-9.1%)
Sep 2004
-
$506.30K(+450.3%)
$957.30K(-29.7%)
Jun 2004
-
$92.00K(-39.1%)
$1.36M(-19.9%)
Mar 2004
-
$151.00K(-27.4%)
$1.70M(-24.8%)
Dec 2003
$2.26M(-48.0%)
$208.00K(-77.2%)
$2.26M(-27.0%)
Sep 2003
-
$911.20K(+112.0%)
$3.10M(-11.3%)
Jun 2003
-
$429.80K(-39.6%)
$3.49M(+3.7%)
Mar 2003
-
$711.30K(-31.8%)
$3.37M(-22.5%)
Dec 2002
$4.34M(+460.9%)
$1.04M(-20.2%)
$4.34M(+31.6%)
Sep 2002
-
$1.31M(+326.9%)
$3.30M(+37.9%)
Jun 2002
-
$306.20K(-81.9%)
$2.39M(+7.5%)
Mar 2002
-
$1.69M(+321.5%)
$2.23M(+137.3%)
Dec 2001
$774.50K(+28.4%)
-
-
Aug 2001
-
$400.30K(+189.0%)
$938.20K(+68.7%)
May 2001
-
$138.50K(+70.1%)
$556.10K(-9.7%)
Feb 2001
-
$81.40K(-74.4%)
$615.60K(+2.1%)
Nov 2000
$603.20K(+363.3%)
$318.00K(+1647.3%)
$603.10K(+298.6%)
Aug 2000
-
$18.20K(-90.8%)
$151.30K(-43.3%)
May 2000
-
$198.00K(+187.4%)
$266.90K(+287.4%)
Feb 2000
-
$68.90K(-151.5%)
$68.90K(>+9900.0%)
Nov 1999
-
-$133.80K(-200.0%)
$0.00(-100.0%)
Aug 1999
-
$133.80K
$133.80K
Nov 1998
$130.20K
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual CAPEX year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Aurinia Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM CAPEX year-on-year change?

What is Aurinia Pharmaceuticals annual capital expenditures?

The current annual CAPEX of AUPH is $281.00K

What is the all time high annual CAPEX for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual capital expenditures is $7.34M

What is Aurinia Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, AUPH annual capital expenditures has changed by -$437.00K (-60.86%)

What is Aurinia Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of AUPH is $17.00K

What is the all time high quarterly CAPEX for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly capital expenditures is $4.28M

What is Aurinia Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, AUPH quarterly capital expenditures has changed by +$5000.00 (+41.67%)

What is Aurinia Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of AUPH is $286.00K

What is the all time high TTM CAPEX for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM capital expenditures is $8.31M

What is Aurinia Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, AUPH TTM capital expenditures has changed by +$65.00K (+29.41%)
On this page